References
- Einstein MH, Schiller JT, Viscidi RP et al. Clinician’s guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect. Dis.9, 347–356 (2009).
- Fauci AS, Johnston MI, Diefenbach, et al. HIV vaccine research: the way forward. Science321, 530–553 (2008).
- Saksena NK, Rodes B, Wang B, Soriano V. Elite HIV controllers; myth or reality. AIDS Reviews9, 195–207 (2007).
- Pereyra F, Addo MM, Kaufmann DE et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis.197, 563–571 (2008).
- Baker BM, Block AC, Rothchild AC, Walker BD. Elite control of HIV infection: implications fro vaccine design. Expert Opin. Biol. Ther.9, 55–69 (2009).
- McMichael AJ. HIV vaccines. Ann. Rev. Immunol.24, 226–255 (2006).
- Walker BD, Burton DR. Towards an AIDS vaccine. Science320, 760–764 (2008).
- Stamatatos L, Morris L, Burton DR, Masccla JR. Neutralising antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine. Nat. Med.15(8), 866–870 (2009).
- Scherer E, Douek D, McMichael A. 25 years of HIV research on virology, virus restriction, immunopathogenesis, genes and vaccines. Clin. Exp. Immunol.154, 6–14 (2008).
- Schmitz JE, Kuroda MJ, Santra S et al. Control of viraemia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science283, 857–860 (2008).
- Klenerman P. T cells get by with a little help from their friends. Eur. J. Immunol.34, 313–316 (2004).
- Watkins DI, Burton DR, Kallas EG, Moore JP, Koff WC. Non human primate models and the failure of the Merck HIV-1 vaccine in humans. Nat. Med.14, 617–621 (2008).
- The rgp120 HIV vaccine study group. Placebo-controlled Phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J. Infect. Dis.191, 654–655 (2005).
- Koff WC, Johnson PR, Watkins DI et al. HIV vaccine design: insights from live attenuated SIV vaccines. Nat. Immunol.7, 19–22 (2006).
- Buchbinder SP, Mehrota DV, Duerr A et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the STEP study): a double blind, randomised placebo-controlled, test-of-concept trial. Lancet372, 1881–1893 (2008).
- Cohen J. HIV/AIDS research. Surprising AIDS vaccine success praised and pondered Science326, 26–27 (2009).